SEC Form 4 · accession 0001192482-15-000376
Zynerba Pharmaceuticals, Inc. · ZYNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas L Harrison
Director
Period of report
Aug 10, 2015
Accepted (ET)
Aug 12, 2015 · 11:48 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001621443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2015 | P | 12,500 | $14.00 | A | 12,500 | D |
Table II — derivative securities
No Table II lines on this filing.